415 related articles for article (PubMed ID: 22744209)
21. Cytosine deaminase adenoviral vector and 5-fluorocytosine selectively reduce breast cancer cells 1 million-fold when they contaminate hematopoietic cells: a potential purging method for autologous transplantation.
Garcia-Sanchez F; Pizzorno G; Fu SQ; Nanakorn T; Krause DS; Liang J; Adams E; Leffert JJ; Yin LH; Cooperberg MR; Hanania E; Wang WL; Won JH; Peng XY; Cote R; Brown R; Burtness B; Giles R; Crystal R; Deisseroth AB
Blood; 1998 Jul; 92(2):672-82. PubMed ID: 9657770
[TBL] [Abstract][Full Text] [Related]
22. Bystander effect caused by cytosine deaminase gene and 5-fluorocytosine in vitro is substantially mediated by generated 5-fluorouracil.
Kuriyama S; Masui K; Sakamoto T; Nakatani T; Kikukawa M; Tsujinoue H; Mitoro A; Yamazaki M; Yoshiji H; Fukui H; Ikenaka K; Mullen CA; Tsujii T
Anticancer Res; 1998; 18(5A):3399-406. PubMed ID: 9858915
[TBL] [Abstract][Full Text] [Related]
23. Low-dose etoposide enhances telomerase-dependent adenovirus-mediated cytosine deaminase gene therapy through augmentation of adenoviral infection and transgene expression in a syngeneic bladder tumor model.
Shieh GS; Shiau AL; Yo YT; Lin PR; Chang CC; Tzai TS; Wu CL
Cancer Res; 2006 Oct; 66(20):9957-66. PubMed ID: 17047058
[TBL] [Abstract][Full Text] [Related]
24. Transduction of thymidine phosphorylase cDNA facilitates efficacy of cytosine deaminase/5-FC gene therapy for malignant brain tumor.
Manome Y; Watanabe M; Abe T; Tomita M; Watanabe S; Yokokawa Y; Takahashi Y; Ishii K; Kimura A; Murakami M; Nagata M; Shibata T; Nakamura M; Tanigawa N; Ohno T
Anticancer Res; 2001; 21(4A):2265-72. PubMed ID: 11724281
[TBL] [Abstract][Full Text] [Related]
25. In vivo preclinical low-field MRI monitoring of tumor growth following a suicide-gene therapy in an orthotopic mice model of human glioblastoma.
Breton E; Goetz C; Kintz J; Accart N; Aubertin G; Grellier B; Erbs P; Rooke R; Constantinesco A; Choquet P
C R Biol; 2010 Mar; 333(3):220-5. PubMed ID: 20338540
[TBL] [Abstract][Full Text] [Related]
26. Pilot trial of genetically modified, attenuated Salmonella expressing the E. coli cytosine deaminase gene in refractory cancer patients.
Nemunaitis J; Cunningham C; Senzer N; Kuhn J; Cramm J; Litz C; Cavagnolo R; Cahill A; Clairmont C; Sznol M
Cancer Gene Ther; 2003 Oct; 10(10):737-44. PubMed ID: 14502226
[TBL] [Abstract][Full Text] [Related]
27. Fusion of the HSV-1 tegument protein vp22 to cytosine deaminase confers enhanced bystander effect and increased therapeutic benefit.
Lee KC; Hamstra DA; Bullarayasamudram S; Bhojani MS; Moffat BA; Dornfeld KJ; Ross BD; Rehemtulla A
Gene Ther; 2006 Jan; 13(2):127-37. PubMed ID: 16163381
[TBL] [Abstract][Full Text] [Related]
28. [Antitumor activity of the recombinant rClone30-CD/5-FC system].
Lu Z; Zhang TY; Han MM; Bai FL; Wu W; Tian GY; Ren GP; Li DS
Yao Xue Xue Bao; 2013 Feb; 48(2):261-8. PubMed ID: 23672024
[TBL] [Abstract][Full Text] [Related]
29. Targeted chemotherapy for head and neck cancer with a chimeric oncolytic adenovirus coding for bifunctional suicide protein FCU1.
Dias JD; Liikanen I; Guse K; Foloppe J; Sloniecka M; Diaconu I; Rantanen V; Eriksson M; Hakkarainen T; Lusky M; Erbs P; Escutenaire S; Kanerva A; Pesonen S; Cerullo V; Hemminki A
Clin Cancer Res; 2010 May; 16(9):2540-9. PubMed ID: 20388844
[TBL] [Abstract][Full Text] [Related]
30. Randomized phase II trial of three intrapleural therapy regimens for the management of malignant pleural effusion in previously untreated non-small cell lung cancer: JCOG 9515.
Yoshida K; Sugiura T; Takifuji N; Kawahara M; Matsui K; Kudoh S; Takada M; Fukuoka M; Ariyoshi Y; Fukuda H; Saijo N
Lung Cancer; 2007 Dec; 58(3):362-8. PubMed ID: 17716779
[TBL] [Abstract][Full Text] [Related]
31. Photochemical Internalization Enhanced Nonviral Suicide Gene Therapy.
Sun CH; Berg K; Hirschberg H
Methods Mol Biol; 2019; 1895():165-176. PubMed ID: 30539537
[TBL] [Abstract][Full Text] [Related]
32. [Adenovirus-mediated double suicide gene therapy for experimental bladder carcinoma].
Tan WL; Xie Y; Wu YD; Zhu WH; Zheng SB
Nan Fang Yi Ke Da Xue Xue Bao; 2006 May; 26(5):594-7. PubMed ID: 16762858
[TBL] [Abstract][Full Text] [Related]
33. Combination of cytosine deaminase suicide gene expression with DR5 antibody treatment increases cancer cell cytotoxicity.
Kaliberov SA; Chiz S; Kaliberova LN; Krendelchtchikova V; Della Manna D; Zhou T; Buchsbaum DJ
Cancer Gene Ther; 2006 Feb; 13(2):203-14. PubMed ID: 16082379
[TBL] [Abstract][Full Text] [Related]
34. Bevacizumab plus chemotherapy for advanced non-squamous non-small-cell lung cancer with malignant pleural effusion.
Kitamura K; Kubota K; Ando M; Takahashi S; Nishijima N; Sugano T; Toyokawa M; Miwa K; Kosaihira S; Noro R; Minegishi Y; Seike M; Yoshimura A; Gemma A
Cancer Chemother Pharmacol; 2013 Feb; 71(2):457-61. PubMed ID: 23178954
[TBL] [Abstract][Full Text] [Related]
35. Cytotoxic effect of replication-competent adenoviral vectors carrying L-plastin promoter regulated E1A and cytosine deaminase genes in cancers of the breast, ovary and colon.
Akbulut H; Zhang L; Tang Y; Deisseroth A
Cancer Gene Ther; 2003 May; 10(5):388-95. PubMed ID: 12719708
[TBL] [Abstract][Full Text] [Related]
36. Antitumor effect of cytosine deaminase/5-fluorocytosine suicide gene therapy system mediated by Bifidobacterium infantis on melanoma.
Yi C; Huang Y; Guo ZY; Wang SR
Acta Pharmacol Sin; 2005 May; 26(5):629-34. PubMed ID: 15842785
[TBL] [Abstract][Full Text] [Related]
37. Monitoring gene therapy with cytosine deaminase: in vitro studies using tritiated-5-fluorocytosine.
Haberkorn U; Oberdorfer F; Gebert J; Morr I; Haack K; Weber K; Lindauer M; van Kaick G; Schackert HK
J Nucl Med; 1996 Jan; 37(1):87-94. PubMed ID: 8544010
[TBL] [Abstract][Full Text] [Related]
38. Combined suicide gene therapy for human colon cancer cells using adenovirus-mediated transfer of escherichia coli cytosine deaminase gene and Escherichia coli uracil phosphoribosyltransferase gene with 5-fluorocytosine.
Koyama F; Sawada H; Hirao T; Fujii H; Hamada H; Nakano H
Cancer Gene Ther; 2000 Jul; 7(7):1015-22. PubMed ID: 10917204
[TBL] [Abstract][Full Text] [Related]
39. Vector targeting makes 5-fluorouracil chemotherapy less toxic and more effective in animal models of epithelial neoplasms.
Akbulut H; Tang Y; Maynard J; Zhang L; Pizzorno G; Deisseroth A
Clin Cancer Res; 2004 Nov; 10(22):7738-46. PubMed ID: 15570008
[TBL] [Abstract][Full Text] [Related]
40. [Impact of intrapleural hyperthermic perfusion on immunologic reaction state of cytokines TH1/TH2 of lung carcinoma patients with malignant pleural effusion].
Kang MQ; Cao YP; Deng F
Ai Zheng; 2008 Feb; 27(2):210-3. PubMed ID: 18279624
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
